All terms in GO

Label Id Description
obsolete sporocyte morphogenesis GO_0010156 [OBSOLETE. Formation and development of sporocyte, the haploid spores of angiosperms which are initiated by the differentiation of a subset of floral cells into sporocytes, which then undergo meiotic divisions to form microspores and megaspores.]
purine ribonucleoside monophosphate metabolic process GO_0009167 [The chemical reactions and pathways involving purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.]
purine nucleoside monophosphate metabolic process GO_0009126 [The chemical reactions and pathways involving purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.]
erythrocyte clearance GO_0034102 [The selective elimination of erythrocytes from the body by autoregulatory mechanisms.]
tissue remodeling GO_0048771 [The reorganization or renovation of existing tissues. This process can either change the characteristics of a tissue such as in blood vessel remodeling, or result in the dynamic equilibrium of a tissue such as in bone remodeling.]
response to chlorate GO_0010157 [Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a chlorate stimulus.]
purine ribonucleoside monophosphate biosynthetic process GO_0009168 [The chemical reactions and pathways resulting in the formation of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.]
purine nucleoside monophosphate biosynthetic process GO_0009127 [The chemical reactions and pathways resulting in the formation of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.]
abaxial cell fate specification GO_0010158 [The process in which a cell becomes capable of differentiating autonomously into an abaxial cell in an environment that is neutral with respect to the developmental pathway; upon specification, the cell fate can be reversed.]
GO_0034100 GO_0034100
specification of animal organ position GO_0010159 [The regionalization process in which information that determines the correct position at which animal organ primordia are formed is generated and perceived resulting in correct positioning of the new animal organ.]
positive regulation of tissue remodeling GO_0034105 [Any process that activates or increases the frequency, rate, or extent of tissue remodeling.]
regulation of tissue remodeling GO_0034103 [Any process that modulates the frequency, rate, or extent of tissue remodeling.]
pollen maturation GO_0010152 [The final stages of microgametogenesis after the trinucleate stage has been reached resulting in viable pollen grains.]
obsolete polar cell elongation GO_0010153 [OBSOLETE. Cell expansion that results in an increase in cell size along the axis of an organ in a polarized fashion.]
regulation of erythrocyte clearance GO_0034106 [Any process that modulates the frequency, rate, or extent of erythrocyte clearance.]
fruit development GO_0010154 [The process whose specific outcome is the progression of the fruit over time, from its formation to the mature structure. The fruit is a reproductive body of a seed plant.]
purine ribonucleoside monophosphate catabolic process GO_0009169 [The chemical reactions and pathways resulting in the breakdown of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.]
purine nucleoside monophosphate catabolic process GO_0009128 [The chemical reactions and pathways resulting in the breakdown of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.]
negative regulation of tissue remodeling GO_0034104 [Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling.]